Skip to content

Intravenous Fluids Versus Naso/Orogastric-tube Feeding in Hospitalized Infants With Bronchiolitis

Intravenous Fluids vs. Naso/Orogastric-tube Feeding in Hospitalized Infants With Acute Viral Bronchiolitis: a Randomized, Controlled, Prospective Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01189149
Enrollment
35
Registered
2010-08-26
Start date
2008-12-31
Completion date
2012-03-31
Last updated
2013-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Viral Bronchiolitis

Brief summary

Oro- or nasogastric tube feeding is safe and may be more physiologic than intravenous (IV) fluids in hospitalized infants with acute viral bronchiolitis.

Interventions

PROCEDUREIV fluids

Infants will be allocated to IV fluids

PROCEDURENaso/oro gastric tube feedings

Infants will be allocated to naso/oro gastric tube feedings

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 6 Months
Healthy volunteers
No

Inclusion criteria

* Infants with bronchiolitis \< 6 months who need to be hospitalized and are not able to eat per os.

Exclusion criteria

* Infants with severe bronchiolitis not allowed to get any gastric feeds or those that their parents will not sign an informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Clinical outcomes3 wintersWill compare clinical outcomes between the groups: Length of stay, need for oxygen, time to full feeds etc.

Secondary

MeasureTime frameDescription
Possible side effects of each method (IV vs. Oro/nasogastric feedings)3 wintersLocal or systemic signs of infection, parainfusion, discomfort while inserting the IV, electrolyte abnormalitis (as part of routine care) vs. aspiration, discomfort with naso/oro gastric tube.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026